You have full access to this article via your institution.
Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here.

Ground squirrels go into a hibernation state called torpor for up to eight months. Credit: Image Professionals GmbH/Alamy
DNA sequences from fossilized poo have revealed that ancient relatives of ground squirrels (Urocitellus sp.) ate a diverse diet of plants, insects and carcasses of megafauna, including woolly mammoths, bison and big cats in a feeding frenzy after they emerged from their winter slumbers. “You can imagine these squirrels emerging from the ground, starting to eat carcasses lying in the environment,” says molecular palaeoecologist Mikkel Pedersen. “They’re zombies of the Pleistocene.” The 700,000-year-old sequences also reveal a previously unknown lineage of ground squirrel and, potentially, North America’s oldest mammoth DNA.
Reference: Nature Communications paper
A tuberculosis vaccine developed in the 1920s helps to regulate blood sugar in people with certain types of diabetes, enabling them to reduce their insulin use. The findings demonstrate yet another beneficial off-target effect of the Bacillus Calmette–Guérin vaccine, derived from a weakened form of the bacterium that causes tuberculosis in cows. The shot has been approved to treat bladder cancer in the United States and is being investigated against conditions such as Alzheimer’s disease. The results were presented at the American Diabetes Association meeting on 7 June.
Almost half of scientists that responded to a Nature poll feel broadly negative towards artificial-intelligence tools — but many feel pressured to use them in their work by a fear of being left behind. In the poll, answered by more than 1,900 researchers, only 23% of respondents felt that AI tools were having a positive impact on research. But most scepticism was directed toward generative tools such as ChatGPT rather than use-specific models, and researchers could see clear benefits for AI use in some areas, such as overcoming language barriers.
Humans have an innate tendency to turn left, and to drift anticlockwise when ambling around. In experiments in which individuals or small groups wandered around an enclosed space, researchers found that people almost always moved anticlockwise, a result that held true across genders and regardless of the person’s dominant leg. Why this happens is unclear, but by working it out, “we could better understand how we perceive the world”, says complex-systems researcher and study co-author Claudio Feliciani. “It can help us make other discoveries which may be more important than this one.”
Reference: Nature Communications paper
Image of the week

The crew of NASA’s next Artemis mission — an Earth-orbiting trip to test equipment and manoeuvres in advance of a Moon landing — has been named as NASA astronauts Andre Douglas, Frank Rubio and Randy Bresnik; and Italian ESA astronaut Luca Parmitano. And they might be going in style: new spacesuits being tested by Axiom Space are worn with a cooling and ventilating onesie designed by fashion house Prada. (BBC | 16 min read & Scientific American | 6 min read) (Axiom Space and Prada)
Features & opinion
Claims that peptides can eliminate wrinkles, build lean muscle, boost metabolism and more abound online. Enthusiasm from proponents, including US health secretary Robert F. Kennedy Jr, has “created this perception that these are miracle drugs”, says longevity researcher Matt Kaeberlein, particularly in the United States. Some peptides — short chains of amino acids — are powerful medicines, such as GLP-1 weight-loss drugs. But there’s little evidence that many of the products touted online are safe or effective in people, and researchers are concerned that unregulated peptide use could have harmful long-term effects.
Groups of researchers — including competitors with disparate expertise — should collaborate on proposals for grant funding to accelerate scientific progress, argues metascientist Sajedeh Rasti. Such applications would bring together usually fragmented strands of research to identify fresh ways to respond to societal challenges. “Selection shifts from the best individual to the best team proposal,” Rasti writes. Collaborative grant writing can lead to a funding system “in which resources are used efficiently, to do better and more important research”.
For people with misophonia, a psychological condition characterized by a severe aversion to sound, everyday noises can trigger a fight-or-flight reaction. The condition can be life-altering, but isn’t currently recognized by the International Classification of Diseases (ICD) system, making it difficult to diagnose and treat. Some researchers are pushing for the ICD to incorporate misophonia, but others argue that we don’t understand the condition well enough yet. Misophonia “doesn’t fit neatly in either the psychiatric or audiological realm”, says clinical psychologist Steven Taylor, which makes it difficult to officially classify.
Today I’ve learned not to rely on a cat in my time of need. Researchers found that unlike dogs and small children, cats won’t lift a paw to help a human that appears to need help — unless it benefits them.
So, maybe I can rely on feline support, as long as I have treats on hand to sweeten the deal.
I hope we can rely on your feedback on this newsletter. Please send any thoughts to [email protected].
Thanks for reading,
Jacob Smith, associate editor, Nature Briefing
With contributions by Flora Graham
• Nature Briefing: Careers — insights, advice and award-winning journalism to help you optimize your working life
• Nature Briefing: Microbiology — the most abundant living entities on our planet — microorganisms — and the role they play in health, the environment and food systems
• Nature Briefing: Anthropocene — climate change, biodiversity, sustainability and geoengineering
• Nature Briefing: AI & Robotics — 100% written by humans, of course
• Nature Briefing: Cancer — a weekly newsletter written with cancer researchers in mind
• Nature Briefing: Translational Research — covers biotechnology, drug discovery and pharma

